Home
Live Updates
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study : comparemela.com
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
/PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics,...
Related Keywords
Daejeon ,
Taejon Gwangyoksi ,
South Korea ,
Quan Dong Nguyen ,
Jin San Yoo ,
Pharmabcine Inc ,
Ir Pr Team ,
Youtube ,
Linkedin ,
Prnewswire Pharmabcine Inc ,
Business Development Team ,
Stanford University ,
Age Related Macular Degeneration ,
Acute Respiratory Distress Syndrome ,
Scientific Advisory Board ,
Pharmabcine ,
comparemela.com © 2020. All Rights Reserved.